256 related articles for article (PubMed ID: 35864548)
1. Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
Yu H; Lv W; Tan Y; He X; Wu Y; Wu M; Zhang Q
J Transl Med; 2022 Jul; 20(1):328. PubMed ID: 35864548
[TBL] [Abstract][Full Text] [Related]
2. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
3. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract][Full Text] [Related]
7. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
Fu X; Yang Y; Zhang X
Front Genet; 2022; 13():919599. PubMed ID: 36134033
[No Abstract] [Full Text] [Related]
8. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer.
Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W
Front Genet; 2022; 13():947216. PubMed ID: 36186479
[No Abstract] [Full Text] [Related]
9. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Xu L; Gao X; Xing J; Guo Z
Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
[TBL] [Abstract][Full Text] [Related]
10. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
11. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
Sun M; Ji X; Xie M; Chen X; Zhang B; Luo X; Feng Y; Liu D; Wang Y; Li Y; Liu B; Xia L; Huang W
Front Immunol; 2022; 13():999084. PubMed ID: 36544770
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
Peng YL; Wang LX; Li MY; Liu LP; Li RS
PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
[TBL] [Abstract][Full Text] [Related]
14. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
15. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.
Zhang F; Qi C; Yao Z; Xu H; Zhou G; Li C; Xia H
Apoptosis; 2023 Dec; 28(11-12):1628-1645. PubMed ID: 37787960
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer.
Xu Y; Zheng Q; Zhou T; Ye B; Xu Q; Meng X
Front Oncol; 2022; 12():887318. PubMed ID: 35686108
[TBL] [Abstract][Full Text] [Related]
18. A novel necroptosis signature for predicting survival in lung adenocarcinoma.
Zang K; Wang M; Zhu X; Yao B; Huang Y
BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445
[TBL] [Abstract][Full Text] [Related]
19. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
20. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment.
Song B; Wu P; Liang Z; Wang J; Zheng Y; Wang Y; Chi H; Li Z; Song Y; Yin X; Yu Z; Song B
Front Genet; 2022; 13():917007. PubMed ID: 35899194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
